Methotrexate Injectable Suppliers & Bulk Manufacturers
Available Forms: Injectable (IV, IM, Subcutaneous)
Available Strengths: 25 mg/mL, 50 mg/mL, 250 mg/10 mL vial
Reference Brands: Trexall (US)
Category: Arthritis
Methotrexate injectable inhibits dihydrofolate reductase, blocking DNA synthesis and cell reproduction. It reduces inflammation and suppresses immune activity, making it effective for rheumatoid arthritis and cancer. Benefits include rapid action, versatile administration, disease modulation, and improved joint function in RA, with a proven safety profile when monitored properly.
Product Description: Methotrexate injectable is approved in the EU and US for treating rheumatoid arthritis, cancer, and autoimmune diseases. In the EU, Pfizer’s Trexall and other generics are regulated by EMA, supported by dossiers demonstrating safety, quality, and efficacy. In the US, FDA approval is based on comprehensive clinical data and biosimilarity assessments. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, registration, and compliance, visit PharmaTradz. We support efficient market access for methotrexate injectable formulations, ensuring adherence to European and American standards for safe, effective treatment of autoimmune and oncological conditions.
Methotrexate Injectable — third party manufacturing & bulk supply
Methotrexate Injectable is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Methotrexate Injectable is supplied as Injectable (IV, IM, Subcutaneous) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Methotrexate Injectable listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Methotrexate Injectable →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Pegloticase Injecatble
Strength:
8 mg/1.2 mL vial
Form: Injectable (IV solution)
Reference Brands: Krystexxa (US)
View Details
Febuxostat Tablets
Strength:
40 mg, 80 mg
Form: Oral Tablets
Reference Brands: Uloric(EU & US)
View Details
Allopurinol Tablets
Strength:
100 mg, 300 mg
Form: Oral Tablets
Reference Brands: Aloprim(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
